Tired of ads? Enjoy an ad-free experience by signing up.
Terence Lee · · 2 min read

Singapore medtech startups get $46M boost from government program

medical medtech

People know the Singapore government to not hold back when it comes to supporting startup initiatives. After all, what’s a little red dot to do when it doesn’t have abundant natural resources and a huge population to lean on?

An announcement yesterday added to that reputation. SPRING Singapore, a government agency that aims to increase the country’s economic growth, has said that it could direct another S$60 million (US$46 million) into Singapore’s medtech startups.

S$30 million will come from the government, while an equal amount deriving from private operators, namely, Zicom MedTacc and Med Tech Alliance. They join existing commercial partners Clearbridge Accelerator and Singapore Medtech Accelerator in the program.

These medtech accelerators will identify, co-invest in, and mentor promising startups on a one-to-one basis with SPRING SEEDS Capital. This program mirrors the ESVF, a government co-investment initiative focusing on internet startups. This S$60 million is the second such injection by the government. The first, consisting of S$40 million, happened in 2011.

SPRING Singapore CEO Tan Kai Hoe explains the program’s rationale: “Entrepreneurs in the medical technology field are often technically and scientifically proficient, but they may lack the know-how and support in developing a market-ready product in this highly complex and regulated environment."

Zicom, a mechanical and precision engineering firm, runs the MedTacc accelerator. It plans to contribute its commercialization, regulatory, manufacturing, and general business expertise, says Zicom executive director Sim Kok Hwee. It would like to back four to 10 early stage companies over four years.

Meanwhile, Med Tech Alliance consists of Accuron Technologies, a precision engineering firm serving the medical, aerospace, and electronics industries; pacemaker battery company Greatbatch; and Lu Yoh-Chie, executive chairman of medtech firm Biosensors.

Four investments were made via the program since its inception.

Editing by Steven Millward, photo by Phalinn Ooi

(And yes, we’re serious about ethics and transparency. More information here.)

Stay ahead in Asia’s tech landscape

You've reached your 2 free content limit for the month. Sign up for free to read the full story.

🏄 For casual readers / 👶 Free

Basic

US$0

Free forever

Get instant access to this article and more every month

0 premium content

Unlimited news briefs

5

5 articles

Ad-free reading experience

Just US$0 per day

⌛Sign up in 20s. No payment details needed.

📖 For learners / 👍 Starter

Lite

US$4.92/month

Billed annually at US$59/year

Get instant access to this article and more every month

4

4 premium content

Unlimited news briefs & articles

Ad-free reading experience

Just US$0.17 per day

Cancel anytime

Our subscriber community includes professionals from these companies:

Stay updated on the go with our mobile app.

Get latest insights with smoother, more personalized experience through TIA mobile app.

TIA Writer

Terence Lee

I like analyzing and digging into the real goings-on in the tech industry. Holds these crypto: BTC, Eth, Matic